When Martin Madaus, Ph.D., became president and CEO of Millipore (Mwww.millipore.com) in January 2005, he immediately began to transform the company into a global supplier of life science tools, ...

Award-winning UCOE TM technology chosen by Astellas for its research programs BILLERICA, Mass., December 4, 2008 Millipore Corporation (NYSE:MIL) today announced it has entered into a worldwide, ...

Germany's Merck KGaA said Sunday that it will pay $6 billion in cash to buy U.S. biotech equipment maker Millipore Corp. in a move to expand its presence beyond drugs and chemicals and into the life ...

Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector Agreed transaction valued at approximately € 5.3 billion ...

BILLERICA — EMD Millipore, begun in 1954 as a local filtration company, is poised to become a much larger player in the fast-growing business of supplying life sciences equipment to drug makers and ...

Bioscience products and services firm Millipore will acquire Serologicals, a specialist in drug discovery equipment and services, for approximately $1.4 billion. Millipore says the acquisition will ...

Millipore Corporation and Serologicals Corporation have announced that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals for $31.55 per share ...

Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE: MIL), a life science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, ...

Millipore, the US-based provider of technologies, tools and services for bioscience research and biopharmaceutical manufacturing, is taking its biopharmaceutical services into Europe with the ...

On Nov. 18, Merck KGaA closed on the biggest acquisition in its 347-year history: The $17.0 billion purchase of the research-chemical supply house Sigma-Aldrich. Announced in September 2014, the deal ...